Drug information for DAUNORUBICIN HYDROCHLORIDE

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
INJECTABLE; INJECTION EQ 5MG BASE/ML Prescription AP (Reference Drug) DAUNORUBICIN HYDROCHLORIDE Daunorubicin BEDFORD 50731
1998-01-30 Review
INJECTABLE; INJECTION EQ 20MG BASE/VIAL Discontinued   DAUNORUBICIN HYDROCHLORIDE Daunorubicin TEVA PARENTERAL 64212
1998-06-23 Letter
INJECTABLE; INJECTION EQ 50MG BASE/VIAL Discontinued   DAUNORUBICIN HYDROCHLORIDE Daunorubicin TEVA PARENTERAL   "
INJECTABLE; INJECTION EQ 20MG BASE/VIAL Prescription AP  DAUNORUBICIN HYDROCHLORIDE Daunorubicin APP PHARMS 65000
1999-05-25 Letter
INJECTABLE; INJECTION EQ 5MG BASE/VIAL Prescription   DAUNORUBICIN HYDROCHLORIDE Daunorubicin APP PHARMS 65034
2001-11-20 Letter
INJECTABLE; INJECTION EQ 5MG BASE/ML Prescription AP  DAUNORUBICIN HYDROCHLORIDE Daunorubicin TEVA PARENTERAL 65035
2000-01-24 Letter

Drug Adverse Effects information for DAUNORUBICIN HYDROCHLORIDE

Role code Indications Reaction # Reports
SS ACUTE LEUKAEMIA CYTOLYTIC HEPATITIS 2
SS ACUTE MYELOID LEUKAEMIA AGITATION 12
SS ACUTE MYELOID LEUKAEMIA BRAIN OEDEMA 12
SS ACUTE MYELOID LEUKAEMIA CAECITIS 8
SS ACUTE MYELOID LEUKAEMIA CONVULSION 12
SS ACUTE MYELOID LEUKAEMIA DEPRESSED LEVEL OF CONSCIOUSNESS 12
SS ACUTE MYELOID LEUKAEMIA DIZZINESS 12
SS ACUTE MYELOID LEUKAEMIA DYSAESTHESIA 12
SS ACUTE MYELOID LEUKAEMIA ENCEPHALOPATHY 12
SS ACUTE MYELOID LEUKAEMIA HEADACHE 12
SS ACUTE MYELOID LEUKAEMIA HYPERSOMNIA 12
SS ACUTE MYELOID LEUKAEMIA HYPERTENSION 8
SS ACUTE MYELOID LEUKAEMIA HYPONATRAEMIA 12
SS ACUTE MYELOID LEUKAEMIA HYPOTENSION 5
SS ACUTE MYELOID LEUKAEMIA NEURALGIA 12
SS ACUTE MYELOID LEUKAEMIA NEUTROPENIC SEPSIS 20
SS ACUTE MYELOID LEUKAEMIA PARAESTHESIA 12
SS ACUTE MYELOID LEUKAEMIA PERIPHERAL SENSORY NEUROPATHY 12
SS ACUTE MYELOID LEUKAEMIA SOMNOLENCE 12
SS ACUTE PROMYELOCYTIC LEUKAEMIA FEBRILE NEUTROPENIA 3
SS ACUTE PROMYELOCYTIC LEUKAEMIA RETINOIC ACID SYNDROME 3
SS CHEMOTHERAPY SHOCK HAEMORRHAGIC 2
SS CLOSTRIDIUM DIFFICILE COLITIS ENTEROCOLITIS INFECTIOUS 1
SS CLOSTRIDIUM DIFFICILE COLITIS FLUID RETENTION 1
SS CLOSTRIDIUM DIFFICILE COLITIS HEADACHE 1
SS CLOSTRIDIUM DIFFICILE COLITIS HYPERTENSION 1
SS CLOSTRIDIUM DIFFICILE COLITIS NEUTROPHIL COUNT DECREASED 1
SS CLOSTRIDIUM DIFFICILE COLITIS WHITE BLOOD CELL COUNT DECREASED 1
SS CROHN'S DISEASE SHOCK HAEMORRHAGIC 10
SS LEUKAEMIA CYTOLYTIC HEPATITIS 1
SS LEUKAEMIA SHOCK HAEMORRHAGIC 2
SS LYMPHOCYTIC LEUKAEMIA ENTEROCOLITIS INFECTIOUS 29
SS LYMPHOCYTIC LEUKAEMIA FLUID RETENTION 29
SS LYMPHOCYTIC LEUKAEMIA HEADACHE 29
SS LYMPHOCYTIC LEUKAEMIA HYPERTENSION 29
SS LYMPHOCYTIC LEUKAEMIA NEUTROPHIL COUNT DECREASED 29
SS LYMPHOCYTIC LEUKAEMIA WHITE BLOOD CELL COUNT DECREASED 29
SS MELAENA SHOCK HAEMORRHAGIC 2
SS MUCOUS MEMBRANE DISORDER SHOCK HAEMORRHAGIC 2
SS MYELODYSPLASTIC SYNDROME NEUTROPENIC SEPSIS 20
SS PRODUCT USED FOR UNKNOWN INDICATION SHOCK HAEMORRHAGIC 6
C ACUTE MYELOID LEUKAEMIA ACUTE GRAFT VERSUS HOST DISEASE 7
C ACUTE MYELOID LEUKAEMIA DIALYSIS 7
C ACUTE MYELOID LEUKAEMIA THROMBOTIC MICROANGIOPATHY 7
C BONE MARROW CONDITIONING REGIMEN ACUTE GRAFT VERSUS HOST DISEASE 1
C BONE MARROW CONDITIONING REGIMEN DIALYSIS 1
C BONE MARROW CONDITIONING REGIMEN THROMBOTIC MICROANGIOPATHY 1
C INFECTION PROPHYLAXIS ACUTE GRAFT VERSUS HOST DISEASE 3
C INFECTION PROPHYLAXIS DIALYSIS 3
C INFECTION PROPHYLAXIS THROMBOTIC MICROANGIOPATHY 3
C PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE ACUTE GRAFT VERSUS HOST DISEASE 2
C PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE DIALYSIS 2
C PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE THROMBOTIC MICROANGIOPATHY 2
Ads by Google